A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide dose-finding information regarding the efficacy and
kinetics of peripheral blood progenitor cell (PBPC) mobilisation by pegfilgrastim and to
determine if carboplatin/paclitaxel can be delivered at a reduced cycle interval when
supported by pegfilgrastim-mobilised PBPCs in whole blood.